ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medical Services

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,738Medicare Part D Prescriptions Filled, Including Refills
$745K Total Retail Price of All Prescriptions
347 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 404 231
AMLODIPINE BESYLATE 346 236
LISINOPRIL 334 186
HYDROCODONE-ACETAMINOPHEN 233 146 S3
METFORMIN HCL 214 96
LEVOTHYROXINE SODIUM 203 127
OMEPRAZOLE 201 127
ZOLPIDEM TARTRATE 186 92
PREDNISONE 158 96
POTASSIUM CHLORIDE 148 69
METOPROLOL SUCCINATE 139 113
FUROSEMIDE 136 93
MELOXICAM 135 76
ATORVASTATIN CALCIUM 129 103
TAMSULOSIN HCL 126 109
LANTUS SOLOSTAR 125 48
LOSARTAN POTASSIUM 124 69
BUMETANIDE 119 88
ALLOPURINOL 116 103
PANTOPRAZOLE SODIUM 115 63
METOPROLOL TARTRATE 112 88
GABAPENTIN 112 71
ROPINIROLE HCL 108 90
CRESTOR 107 68
CLOPIDOGREL 107 84
ZETIA 106 53
CARVEDILOL 99 57
AZITHROMYCIN 97 59
PROAIR HFA 93 42
FENOFIBRATE 89 74
SPIRIVA 87 43
GLIMEPIRIDE 81 53
TRAMADOL HCL 78 48
NEXIUM 78 68
FLUCONAZOLE 77 19
JANUVIA 77 42
SERTRALINE HCL 74 50
CITALOPRAM HBR 73 38
PLAVIX 73 60
ONGLYZA 70 50
ALENDRONATE SODIUM 70 53
NOVOLOG FLEXPEN 70 31
SYMBICORT 69 32
WARFARIN SODIUM 67 36
CLONIDINE HCL 66 30
ACTOS 65 43
BYSTOLIC 64 63
DIOVAN 60 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 17
POLYETHYLENE GLYCOL 3350 56 37
LOSARTAN-HYDROCHLOROTHIAZIDE 54 47
RANITIDINE HCL 54 37
FLUOXETINE HCL 52 27
HYDROCHLOROTHIAZIDE 51 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.